Scientific Poster , Human ADME , Clinical Pharmacology

ISSX 2017 Poster: Using 14C radiolabeled clinical studies to explore and evaluate factors influencing oral exposure

6 November 2017
  • Home
  • Resources
  • ISSX 2017 Poster: Using 14C radiolabeled clinical studies to explore and evaluate factors influencing oral exposure
Overview

This poster describes a 2 part study combining an IV microtracer study with a conventional oral ADME study.

Read our ISSX scientific poster today titled, 'Using 14C Radiolabeled Clinical Studies to Explore and Evaluate Factors Influencing Oral Exposure.'

Download
Download Now
Date
6 November 2017

Your challenges. Our solutions.

Learn more about our expertise in human ADME studies.

Contact Us
Quotient Sciences Logo
Human ADME, Regulatory

Assessing the Impact of the Approved FDA Guidance on Human Mass Balance Studies: How ADME programs will proceed in 2024 and beyond

By: Dr. Adam Robinson-Miller Read More

More about our human ADME capabilities

Browse More
Info Sheet, Human ADME, Radiosynthesis, Clinical Pharmacology
Human ADME Capabilities
Download Now
Whitepaper, Human ADME
Synthesis-to-Clinic®: A streamlined approach to 14C human ADME studies
Download Now
Browse More
Get in touch
Humanity can't afford to wait, so neither can we.
Let's talk